Pharmafile Logo
Pharmafocus logo
Advanced Search
cosentyx_logo

Novartis’ Cosentyx gets European approval for two conditions

October 23, 2015
Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis

The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …

News
amgen_hq

Amgen skin cancer drug gets European approval

October 23, 2015
Research and Development Amgen, Imlygic, melanoma, skin cancer

Amgen’s Imlygic (talimogene laherparepvec) has been approved by the scientific committee of the European Medicines Agency (EMA) for the treatment of adults …

News
richard_erwin

New general manager for Roche UK

October 23, 2015
Medical Communications

Richard Erwin has joined Roche as the new UK General Manager.Richard’s passion for driving sustainable change and championing patient needs …

Appointment
Viekira Pak logo

FDA warns AbbVie hep C drugs linked to serious liver damage

October 23, 2015
Medical Communications AbbVie

AbbVie stocks tumbled 14% yesterday after the FDA warned that two of the company’s hepatitis C drugs could cause serious …

News

OLS backs UK to become global digital health leader

October 23, 2015
Medical Communications Big Data, Office for Life Sciences, digital health, health analytics, mhealth, patient records, telehealth, telehealthcare

The UK market has the potential to lead the world in digital health – if certain barriers are overcome – …

News
New Merck logo

COMPANY PROFILE: The secrets of that Merck rebrand

October 23, 2015
Medical Communications, Sales and Marketing Merck, branding, communications, corporate logo, reputation

Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …

Feature
gilead-sciences

Gilead presents Phase III results for Genvoya in HIV

October 22, 2015
Medical Communications, Research and Development Genvoya, Gilead Sciences, HIV

Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …

News
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015
Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

News
bmss_orencia_was_recommended_in_draft_guidance

NICE recommends four treatments for arthritis in children

October 22, 2015
Medical Communications, Research and Development NICE, arthritis, jia

 UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

News
uk_china_flags_half_and_half

UK and China sign £2 billion in healthcare trade and investment deals

October 22, 2015
Research and Development

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …

News
pi

Physicians Interactive acquires Univadis portal

October 22, 2015
Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …

News
mgt_kingsley

Executive vice president Tony Kingsley leaves Biogen

October 22, 2015
Biogen, John Cox, Tony Kingsley

Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …

Appointment
Severin Schwan

Roche buoyed by 6% sales growth

October 22, 2015
Sales and Marketing Roche, financial results

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

News
Aspirin

World’s largest clinical trial of aspirin in cancer launches in UK

October 22, 2015
Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …

News
biogen_logo

Revenues up at Biogen – but job losses planned

October 22, 2015
Biogen, financial results, job losses, redundancies

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

News
Biogen image

Biogen’s natalizumab fails Phase III endpoints

October 21, 2015
Biogen, multiple sclerosis

Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …

News
Stelera

Encouraging late-stage results for Stelara in Crohn’s disease

October 21, 2015
Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …

News
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

Appointment
heather_grant

DNA expands in London, appointing Heather Grant to lead new division

October 21, 2015
Medical Communications

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

News
kidney

Featured Market Report – Kidney Disease Global Clinical Trials Review

October 21, 2015
Research and Development

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …

Feature
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026